Rigel Pharmaceuticals (RIGL) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 24.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.42% |
| Dec 31, 2025 | -132.38% |
| Sep 30, 2025 | -972.57% |
| Jun 30, 2025 | -312.97% |
| Mar 31, 2025 | -3,471.25% |
| Dec 31, 2024 | -58.77% |
| Sep 30, 2024 | 424.96% |
| Jun 30, 2024 | 267.98% |
| Mar 31, 2024 | -59.72% |
| Dec 31, 2023 | -136.96% |
| Sep 30, 2023 | -111.19% |
| Jun 30, 2023 | -85.92% |
| Mar 31, 2023 | -96.57% |
| Dec 31, 2022 | 186.65% |
| Sep 30, 2022 | 123.55% |
| Jun 30, 2022 | 142.48% |
| Mar 31, 2022 | 200.44% |
| Dec 31, 2021 | -25.52% |
| Sep 30, 2021 | -327.35% |
| Jun 30, 2021 | -848.78% |
| Mar 31, 2021 | -69.21% |
| Dec 31, 2020 | 214.36% |
| Sep 30, 2020 | 6,742.18% |
| Jun 30, 2020 | 64.33% |
| Mar 31, 2020 | 2,379.68% |
| Dec 31, 2019 | -463.93% |
| Sep 30, 2019 | -101.85% |
| Jun 30, 2019 | 9.44% |
| Mar 31, 2019 | -104.62% |
| Dec 31, 2018 | 105.94% |
| Sep 30, 2018 | 109.69% |
| Jun 30, 2018 | -293.90% |
| Mar 31, 2018 | 15,578.67% |
| Dec 31, 2017 | -1,769.35% |
| Sep 30, 2017 | -27.25% |
| Jun 30, 2017 | -56.36% |
| Mar 31, 2017 | 97.78% |
| Dec 31, 2016 | -83.44% |
| Sep 30, 2016 | -66.09% |
| Jun 30, 2016 | 330.87% |
| Mar 31, 2016 | -171.19% |
| Dec 31, 2015 | -24.61% |
| Sep 30, 2015 | 319.58% |
| Jun 30, 2015 | -129.35% |
| Mar 31, 2015 | -9.07% |
| Dec 31, 2014 | -28.02% |
| Sep 30, 2014 | -51.00% |
| Jun 30, 2014 | 244.24% |
| Mar 31, 2014 | -59.44% |
| Dec 31, 2013 | 121.70% |
| Sep 30, 2013 | -21.87% |
| Jun 30, 2013 | -65.76% |
| Mar 31, 2013 | -1.52% |
| Dec 31, 2012 | -707.04% |
| Sep 30, 2012 | 265.93% |
| Jun 30, 2012 | 122.41% |
| Mar 31, 2012 | -30.71% |
| Dec 31, 2011 | 174.46% |
| Sep 30, 2011 | -229.61% |